LAM LE: Open Payments
NPI 1164824066 · MERCED, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,638 in 154 payments from 21 companies in 2025. Trend: 2023 $1,378 · 2024 $2,739 · 2025 $2,638
Food & beverage: $2,440Education: $198
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $431 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $341 |
| Incyte Corporation | 22 | $335 |
| Lilly USA, LLC | 19 | $298 |
| Janssen Biotech, Inc. | 11 | $202 |
| UCB, Inc. | 11 | $172 |
| Regeneron Healthcare Solutions, Inc. | 10 | $150 |
| Arcutis Biotherapeutics, Inc. | 10 | $146 |
| Galderma Laboratories, L.P. | 12 | $140 |
| Novartis Pharmaceuticals Corporation | 4 | $100 |
Products named: OPZELURA, SKYRIZI, TALTZ, TREMFYA, DUPIXENT, Bimzelx, Zoryve, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
